血清VEGF、TPS及CEA在结直肠癌诊断中的研究进展  

Research Progress of Serum VEGF,TPSA and CEA in the Diagnosis of Colorectal Cancer

作　　者：汪家航 林明强 WANG Jiahang;LIN Mingqiang(Second General Hospital of Fuzhou City,Fuzhou 350007,China;不详)

机构地区：[1]福州市第二总医院,福建福州350007

出　　处：《中外医学研究》2024年第24期179-181,共3页CHINESE AND FOREIGN MEDICAL RESEARCH

基　　金：2021年福州市卫生健康中青年科学研究项目(2021-S-wq19);福建省创伤骨科急救与康复临床医学研究中心项目(2020Y2014)。

摘　　要：随着医学科技的不断发展,人们对于结直肠癌的诊断方法也在不断追求更加精确和高效的手段。血清血管内皮生长因子(VEGF)、组织多肽特异性抗原(TPS)和癌胚抗原(CEA)作为结直肠癌诊断的重要标志物,近年来受到了广泛关注。本文主要从VEGF、TPS、CEA三方面入手,对血清血管内皮VEGF、TPSA、CEA三项指标检测,在结直肠癌诊断过程中所发挥的作用的研究进展情况实施综述。With the continuous development of medical technology,people are constantly pursuing more accurate and efficient diagnostic methods for colorectal cancer.Serum vascular endothelial growth factor(VEGF),tumor specific growth factor(TSGF)and carcinoembryonic antigen(CEA),as important biomarkers for the diagnosis of colorectal cancer,have received widespread attention in recent years.This article mainly starts with VEGF,TPS and CEA,and reviews the research progress on the role of serum vascular endothelial VEGF,TPSA and CEA in the diagnosis of colorectal cancer.

关 键 词：血管内皮生长因子 组织多肽特异性抗原 癌胚抗原 结直肠癌 诊断 

分 类 号：R735.34[医药卫生—肿瘤]